abs168.txt	background		the	musashi	(msi)	family	of	rna-binding	proteins	is	best	known	forthe	role	in	post-transcriptional	regulation	of	target	mrnas		elevated	msi1	levelsin	a	variety	of	human	cancer	are	associated	with	up-regulation	of	notch/wntsignaling		msi1	binds	to	and	negatively	regulates	translation	of	numb	and	apc(adenomatous	polyposis	coli)		negative	regulators	of	notch	and	wnt	signalingrespectively	methods		previously		we	have	shown	that	the	natural	product	(-)-gossypol	as	thefirst	known	small	molecule	inhibitor	of	msi1	that	down-regulates	notch/wntsignaling	and	inhibits	tumor	xenograft	growth	in	vivo		using	a	fluorescencepolarization	(fp)	competition	assay		we	identified	gossypolone	(gn)	witha	>	20-fold	increase	in	ki	value	compared	to	(-)-gossypol		we	validated	gnbinding	to	msi1	using	surface	plasmon	resonance		nuclear	magnetic	resonance		andcellular	thermal	shift	assay		and	tested	the	effects	of	gn	on	colon	cancer	cellsand	colon	cancer	dld-1	xenografts	in	nude	mice	results		in	colon	cancer	cells		gn	reduced	notch/wnt	signaling	and	inducedapoptosis		compared	to	(-)-gossypol		the	same	concentration	of	gn	is	less	activein	all	the	cell	assays	tested		to	increase	gn	bioavailability		we	used	pegylatedliposomes	in	our	in	vivo	studies		gn-lip	via	tail	vein	injection	inhibited	thegrowth	of	human	colon	cancer	dld-1	xenografts	in	nude	mice		as	compared	to	theuntreated	control	(p	<	0	01		n	=	10)	conclusion		our	data	suggest	that	pegylation	improved	the	bioavailability	of	gnas	well	as	achieved	tumor-targeted	delivery	and	controlled	release	of	gn		whichenhanced	its	overall	biocompatibility	and	drug	efficacy	in	vivo		this	providesproof	of	concept	for	the	development	of	gn-lip	as	a	molecular	therapy	for	coloncancer	with	msi1/msi2	overexpression	
